跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 156 条关于
“MindMED”
全部
156
临床试验
82
药物
6
机构
10
资讯
58
去年
MindMed Reports Strong Financial Position with $273.7M Cash Reserve, Extending Operations Through 2027
2年前
MindMed Advances LSD Development Program for Major Depressive Disorder Treatment
去年
MindMed Appoints Matt Wiley as Chief Commercial Officer to Lead MM120 Launch Strategy
去年
MindMed Initiates Phase III Trial of MM120 (LSD) for Generalized Anxiety Disorder
去年
MindMed Reports Strong Financial Position and Progress in Anxiety Treatment Development
去年
MindMed Advances MM120 for GAD with Phase 3 Trials Underway
去年
MindMed's MM120 Advances in Phase III Trials for GAD and MDD, Stock Surges
去年
Altimmune and MindMed Join Nasdaq Biotechnology Index, Anticipate Key Clinical Data in 2025
去年
MindMed to lead first LSD Phase 3 trials for anxiety - Drug Discovery and Development
8个月前
MindMed Rebrands as Definium Therapeutics, Prepares for Three Phase 3 Psychedelic Therapy Readouts in 2026
第 1 页,共 6 页
上一页
下一页